profit from every $100 of sales.
$0$100
AdaptHealth
$7.80+1.04% today
-18.2% in 1 year
1-year low $5.221-year high $13.38
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What AdaptHealth sold, what it kept, and what it did with the cash.
Sales went from $2.97 billion in 2022 to $3.24 billion in 2025, with -$70.8 million of profit last year.
SalesProfit
AdaptHealth vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| AdaptHealth | No profit yet | ||
 Boston Scientific | 22.6× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.8× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads AdaptHealth's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,971 | 3,200 | 3,261 | 3,245 | |
| 580 | 624 | 681 | 609 | |
| 190 | 232 | 277 | 186 | |
| 558 | -211 | 628 | 473 | |
| 69 | -679 | 90 | -71 | |
| 0.33 | -5.31 | 0.61 | -0.52 | |
| 19.5% | 19.5% | 20.9% | 18.8% | |
| 6.4% | 7.3% | 8.5% | 5.7% | |
| 2.3% | -21.2% | 2.8% | -2.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 5,220 | 4,509 | 4,487 | 4,317 |
| Cash | 46 | 77 | 110 | 106 |
| Total debt | 2,329 | 2,295 | 2,130 | 1,903 |
| Total liabilities | 3,062 | 3,042 | 2,909 | 2,790 |
| 2,151 | 1,458 | 1,571 | 1,519 | |
| 139 | 134 | 136 | 135 | |
| 3.7% | -12.5% | 5.6% | 2.1% | |
| 3.2% | -46.5% | 5.8% | -4.7% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 374 | 481 | 542 | 602 | |
| 391 | 337 | 306 | 382 | |
| -18 | 143 | 236 | 219 | |
| Dividends paid | – | – | – | – |
| 14 | 29 | 0 | 0 | |
| 22 | 22 | 15 | 22 |
Valuation
- –
- 7.8×
- –
- 1.0×
- 0.3×
- 4.9×
- 6.1×
- 20.6%
- -6.6%
- 0.0%
Profitability
- 18.8%
- 5.7%
- -2.2%
- 16.8%
- 5.5%
- -2.5%
- -5.1%
- -1.8%
- 5.6%
- –
Growth
- +3.0%
- –
- −7.0%
- –
- +1.7%
Financial health
- 4.1×
- 1.33
- 45.2%
- 2.0×
- 0.92
- 0.71
- 0.65
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 49%of 958
Bottom 40%of 888
Bottom 24%of 889
Top 3%of 987
What analysts expect
- Average price target
- $12.00
- Range
- $11.00 – $13.00
- 3 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | -0.06 | 0.01 | −580.0% |
| Feb 24, 2026 | 0.27 | 0.34 | −20.6% |
| Nov 4, 2025 | 0.22 | 0.24 | −8.3% |
| Aug 5, 2025 | 0.01 | 0.15 | −93.3% |
| May 6, 2025 | 0.01 | 0.01 | +0.0% |
| Feb 25, 2025 | 0.39 | 0.25 | +56.0% |
| Nov 5, 2024 | 0.15 | 0.17 | −11.8% |
| Aug 6, 2024 | 0.21 | 0.19 | +10.5% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
23No pass
Benjamin Graham
41No pass
Philip Fisher
17No pass
Peter Lynch
24No pass
Joel Greenblatt
0No pass
Charlie Munger
9No pass
Terry Smith
6No pass
Questions about AdaptHealth
Is AdaptHealth a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the AdaptHealth AI analysis
What does AdaptHealth do?
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. It is in Medical - Devices.
Does AdaptHealth pay a dividend?
No. AdaptHealth does not pay a dividend at the moment.
Is AdaptHealth stock halal?
No. AdaptHealth does not pass our halal screen: its debt is 179% of its market value, at or above the 33% limit. How we check
How has AdaptHealth stock done over the past year?
Down 18.2% over the past twelve months, to $7.80. It traded between $5.22 and $13.38 and is 41.7% below its high.
Who are AdaptHealth's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with AdaptHealth's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.